ELIZABETH FROMAN: Open Payments
NPI 1821031295 · SPRINGDALE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$31,475 in 38 payments from 9 companies in 2025. Trend: 2023 $30,122 · 2024 $31,440 · 2025 $31,475
Consulting: $31,200Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| CSL Plasma Inc. | 20 | $31,200 |
| Collegium Pharmaceutical, Inc. | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Kowa Pharmaceuticals America, Inc. | 2 | $33 |
| Corium, LLC | 5 | $29 |
| The Binding Site Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: REXULTI, Jornay PM, ZORYVE, Azstarys, Freelite, CAPLYTA, SPRAVATO.
Industry payments across AR — which companies pay providers there.
